News for Healthier Living

SPRED2 loss drives liver cancer stemness via p53/miR-506-3p/KLF4

Researchers have identified a new tumor-suppressive circuit that controls stem-like behavior in hepatocellular carcinoma (HCC). The work shows that Sprouty-related, EVH1 domain-containing protein 2 (SPRED2) binds the tumor suppressor p53, enters the nucleus, and activates transcription of the microRNA miR-506-3p. In turn, miR-506-3p directly targets KLF4 messenger RNA, lowering KLF4 protein and reducing cancer stem cell (CSC) traits, including sphere formation, colony growth, invasion, and aldehyde dehydrogenase (ALDH) activity. The study defines a SPRED2/p53/miR-506-3p/KLF4 axis and suggests that restoring this pathway could help suppress HCC progression, recurrence, and treatment resistance.

October 8, 2026


October 14 2026

October 13 2026

October 12 2026

October 11 2026

October 10 2026

October 9 2026

October 8 2026

October 7 2026

October 6 2026

October 5 2026

October 2 2026

October 1 2026

September 30 2026